Mirja Tiikkainen

Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insulin Resistance, Insulin Clearance, and Gene Expression in Adipose Tissue in Patients With Type 2 Diabetes

Mirja Tiikkainen, Anna‐Maija Häkkinen, Elena Korsheninnikova et al. · Diabetes · 2004 · 524 citations · Full text

Liver Fat Content, Fatty Liver Disease, Insulin Signaling +19

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

H Yki-Järvinen, Mirja Tiikkainen, Markku Vähätalo et al. · Diabetologia · 2006 · 435 citations · Full text

Metabolic Syndrome, Diabetes Management, Insulin Glargine +10

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

Jukka Westerbacka, A. Corn�r, Mirja Tiikkainen et al. · Diabetologia · 2004 · 338 citations · Full text

Obesity, Metabolic Syndrome, Body Composition +13

Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes

Anna Kotronen, Leena Juurinen, Mirja Tiikkainen et al. · Gastroenterology · 2008 · 335 citations · Full text

Insulin Resistance, Metabolic Syndrome, Obesity +14

Effects of Identical Weight Loss on Body Composition and Features of Insulin Resistance in Obese Women With High and Low Liver Fat Content

Mirja Tiikkainen, Robert Bergholm, Satu Vehkavaara et al. · Diabetes · 2003 · 272 citations · Full text